5-hydroxytryptamine (5HT) receptors in the heart valves of cynomoigus monkeys and Sprague-Dawley rats

被引:29
作者
Elangbam, CS
Lightfoot, RM
Yoon, LW
Creech, DR
Geske, RS
Crumbley, CW
Gates, LD
Wall, HG
机构
[1] GlaxoSmithKline, Dept Pathol, Res Triangle Pk, NC 27709 USA
[2] GlaxoSmithKline, Safety Assessment, Res Triangle Pk, NC 27709 USA
[3] GlaxoSmithKline, Investigat Toxicol & Pathol, Res Triangle Pk, NC 27709 USA
[4] GlaxoSmithKline, Quantitat Express & Genom Histol, Res Triangle Pk, NC 27709 USA
关键词
heart valve; 5-hydroxytryptamine (5HT) receptor; immunolhistochemistry; TaqMan; cynomolgus monkey; Sprague-Dawley rat;
D O I
10.1369/jhc.4A6500.2005
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
5-Hydroxytryptamine-2B receptor (5HT2BR) stimulation is known to cause fibroblast mitogenesis, and the mitogenic effect has been proposed to trigger valvular heart disease in humans. In this study, we used real-time polymerase chain reaction (TaqMan) to quantify transcript levels of 5HT2B, 5HT2C, and 5HT1B receptors and immunohistochemistry (IHC) to detect the tissue localization of these receptors in the normal heart valves of cynomolgus (CM) monkeys and Sprague-Dawley (S-D) rats. in both species, positive immunostaining was noted for 5HT1B and 5HT2B receptors in mitral, tricuspid, aortic, and pulmonary valves, and the cell types showing positive staining were interstitial cells and endothelial cells lining the valve leaflet. In CM monkeys, 5HT2CR was expressed only in the endothelial cells lining the leaflet, whereas S-D valves were negative for this receptor. IHC results were correlated with 5HT2B and 5HT1B receptor transcripts for all four valves. However, 5HT2C receptor transcripts were lower than 5HT2B or 5HT1B in all CM monkey valves, whereas 5HT2C transcripts were below the level of detection in any of the S-D rat valves. Our data showed the expression of 5HT2B, 5HT1B, and 5HT2C receptors in the normal heart valves of CM monkeys and S-D rats, and IHC and TaqMan techniques may be used to study the potential mechanism of compounds with 5HT2BR agonist activity.
引用
收藏
页码:671 / 677
页数:7
相关论文
共 22 条
[1]   5-HT2 RECEPTOR SUBTYPES - A FAMILY RE-UNITED [J].
BAXTER, G ;
KENNETT, G ;
BLANEY, F ;
BLACKBURN, T .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (03) :105-110
[2]   Immunohistochemical localisation of the serotonin 5-HT2B receptor in mouse gut, cardiovascular system, and brain [J].
Choi, DS ;
Maroteaux, L .
FEBS LETTERS, 1996, 391 (1-2) :45-51
[3]   Valvular heart disease associated with fenfluramine-phentermine [J].
Connolly, HM ;
Crary, JL ;
McGoon, MD ;
Hensrud, DD ;
Edwards, BS ;
Edwards, WD ;
Schaff, HV .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) :581-588
[4]  
Fitzgerald LW, 2000, MOL PHARMACOL, V57, P75
[5]   Further cases of valvular heart disease associated with fenfluramine-phentermine [J].
Graham, DJ ;
Green, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) :635-635
[6]   Molecular, pharmacological and functional diversity of 5-HT receptors [J].
Hoyer, D ;
Hannon, JP ;
Martin, GR .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2002, 71 (04) :533-554
[7]   Serotonin mechanisms in heart valve disease I -: Serotonin-induced up-regulation of transforming growth factor-β1 via G-protein signal transduction in aortic valve interstitial cells [J].
Jian, B ;
Xu, J ;
Connolly, J ;
Savani, RC ;
Narula, N ;
Liang, B ;
Levy, RJ .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (06) :2111-2121
[8]   A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation [J].
Jick, H ;
Vasilakis, C ;
Weinrauch, LA ;
Meier, CR ;
Jick, SS ;
Derby, LE .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (11) :719-724
[9]  
Kurz X, 1997, NEW ENGL J MED, V337, P1772
[10]   Functional consequence of serotonin/5-HT2B receptor signaling in heart role of mitochondria in transition between hypertrophy and heart failure? [J].
Nebigil, CG ;
Maroteaux, L .
CIRCULATION, 2003, 108 (07) :902-908